School of Nutrition, Laval University, Québec City, Québec, Canada.
Endocrinology and Nephrology Unit, CHU of Québec Research Center-Laval University, Québec City, Québec, Canada.
J Nutr. 2021 Jul 1;151(7):1937-1946. doi: 10.1093/jn/nxab060.
The evolution of vitamin D status across pregnancy trimesters and its association with prepregnancy body mass index (ppBMI; in kg/m2) remain unclear.
We aimed to 1) assess trimester-specific serum total 25-hydroxyvitamin D [25(OH)D] concentrations, 2) compare those concentrations between ppBMI categories, and 3) examine associations between 25(OH)D concentrations, ppBMI, and vitamin D intake.
As part of a prospective cohort study, 79 pregnant women with a mean age of 32.1 y and ppBMI of 25.7 kg/m2 were recruited in their first trimester (average 9.3 weeks of gestation). Each trimester, vitamin D intake was assessed by 3 Web-based 24-h recalls and a Web questionnaire on supplement use. Serum total 25(OH)D was measured by LC-tandem MS. Repeated-measures ANOVA was performed to assess the evolution of 25(OH)D concentrations across trimesters of pregnancy and comparisons of 25(OH)D concentrations between ppBMI categories were assessed by 1-factor ANOVAs. Stepwise regression analyses were used to identify determinants of 25(OH)D concentrations in the third trimester.
Mean ± SD serum total 25(OH)D concentrations increased across trimesters, even after adjustments for ppBMI, seasonal variation, and vitamin D intake from supplements (67.5 ± 20.4, 86.5 ± 30.9, and 88.3 ± 29.0 nmol/L at mean ± SD 12.6 ± 0.8, 22.5 ± 0.8, and 33.0 ± 0.6 weeks of gestation, respectively; P < 0.0001). In the first and third trimesters, women with a ppBMI ≥30 had lower serum total 25(OH)D concentrations than women with a ppBMI <25 (P < 0.05); however, most had concentrations >40nmol/L by the second trimester. Vitamin D intake from supplements was the strongest determinant of third-trimester serum total 25(OH)D concentrations (r2 = 0.246, β = 0.51; P < 0.0001).
There was an increase in serum total 25(OH)D concentrations across trimesters, independent of ppBMI, seasonal variation, and vitamin D intake from supplements. Almost all women had serum total 25(OH)D concentrations over the 40- and 50-nmol/L thresholds, thus our study supports the prenatal use of a multivitamin across pregnancy.
孕期各 trimester 维生素 D 状况的演变及其与孕前体重指数(ppBMI;以 kg/m2 表示)的关系仍不清楚。
我们旨在 1)评估特定 trimester 的血清总 25-羟维生素 D [25(OH)D] 浓度,2)比较不同 ppBMI 类别之间的浓度,3)检查 25(OH)D 浓度、ppBMI 和维生素 D 摄入量之间的关联。
作为一项前瞻性队列研究的一部分,招募了 79 名平均年龄为 32.1 岁且 ppBMI 为 25.7kg/m2 的孕妇,招募时间为孕早期(平均妊娠 9.3 周)。每个 trimester,通过 3 次基于网络的 24 小时回忆和基于网络的补充剂使用问卷评估维生素 D 摄入量。通过 LC-串联 MS 测量血清总 25(OH)D。重复测量方差分析用于评估孕期各 trimester 25(OH)D 浓度的演变,单因素方差分析用于评估不同 ppBMI 类别之间的 25(OH)D 浓度比较。逐步回归分析用于确定第三个 trimester 25(OH)D 浓度的决定因素。
即使在校正了 ppBMI、季节性变化和补充剂中的维生素 D 摄入量后,血清总 25(OH)D 浓度仍随着 trimester 的增加而增加(分别在平均 12.6 ± 0.8、22.5 ± 0.8 和 33.0 ± 0.6 孕周时,平均值 ± 标准差为 67.5 ± 20.4、86.5 ± 30.9 和 88.3 ± 29.0nmol/L;P<0.0001)。在第一和第三个 trimester,ppBMI≥30 的女性血清总 25(OH)D 浓度低于 ppBMI<25 的女性(P<0.05);然而,大多数女性在第二个 trimester 时的浓度就已超过 40nmol/L。补充剂中的维生素 D 摄入量是第三个 trimester 血清总 25(OH)D 浓度的最强决定因素(r2=0.246,β=0.51;P<0.0001)。
血清总 25(OH)D 浓度随 trimester 的增加而增加,独立于 ppBMI、季节性变化和补充剂中的维生素 D 摄入量。几乎所有女性的血清总 25(OH)D 浓度都超过了 40-和 50-nmol/L 阈值,因此我们的研究支持整个孕期使用多种维生素。